Publication:
Effects of endocrine-disrupting chemicals on obesity and diabetes

dc.contributor.authorCander, Soner
dc.contributor.authorYetkin, İlhan
dc.contributor.buuauthorCANDER, SONER
dc.contributor.departmentBursa Uludağ Üniversitesi/Tıp Fakültesi/Endokrinoloji ve Metabolizma Anabilim Dalı
dc.contributor.researcheridCJH-1319-2022
dc.date.accessioned2024-09-12T05:43:40Z
dc.date.available2024-09-12T05:43:40Z
dc.date.issued2023-10-01
dc.description.abstractThe increasing incidence of obesity and type 2 diabetes mellitus (T2DM) is a global problem. Although the obesity epidemic is mostly associated with a lack of physical activity and diet, several chemicals have been demonstrated to have a potential role in its pathophysiological mechanisms. An accumulating volume of evidence indicates that a subclass of endocrine-disrupting chemicals (EDCs) can impair hormonally regulated metabolic processes, particularly in the case of exposure early in life when the defense mechanisms of the human body are yet to be fully developed. These chemicals are called "obesogenic EDCs" and might cause some people to gain weight despite their attempts to increase physical activity and limit calorie intake. Similarly, background exposure to some environmental EDCs has been associated with diabetes and impaired glucose metabolism. Certain widespread EDCs, including pesticides, dioxins, and bisphenol A, in animal models may change beta function and insulin resistance. These EDCs, which may accumulate in adipose tissue and cause a pro-inflammatory response, can also be found at measurable levels in human blood and can either imitate or block some hormonal reactions. In this review, we evaluate EDCs in relation to obesity and T2DM in light of the current literature.
dc.identifier.doi10.5152/erp.2023.23309
dc.identifier.eissn2822-6135
dc.identifier.endpage240
dc.identifier.issue4
dc.identifier.startpage233
dc.identifier.urihttps://doi.org/10.5152/erp.2023.23309
dc.identifier.urihttps://www.endocrinolrespract.org//en/effects-of-endocrine-disrupting-chemicals-on-obesity-and-diabetes-131182
dc.identifier.urihttps://eds.p.ebscohost.com/eds/pdfviewer/pdfviewer
dc.identifier.urihttps://hdl.handle.net/11452/44606
dc.identifier.volume27
dc.identifier.wos001097937500009
dc.indexed.wosWOS.ESCI
dc.language.isoen
dc.publisherAves
dc.relation.journalEndocrinology Research and Practice
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectBisphenol-a
dc.subjectOrganotin compounds
dc.subjectMetabolic syndrome
dc.subjectAdipose-tissue
dc.subjectHuman health
dc.subjectStem-cells
dc.subjectTributyltin
dc.subjectInsulin
dc.subjectExposure
dc.subjectAdipogenesis
dc.subjectDiabetes
dc.subjectEdc
dc.subjectEndocrine-disrupting chemicals
dc.subjectMetabolic syndrome
dc.subjectObesity
dc.subjectScience & technology
dc.subjectLife sciences & biomedicine
dc.subjectEndocrinology & metabolism
dc.titleEffects of endocrine-disrupting chemicals on obesity and diabetes
dc.typeReview
dspace.entity.typePublication
relation.isAuthorOfPublication7e655938-5300-4433-810e-24945b8c2774
relation.isAuthorOfPublication.latestForDiscovery7e655938-5300-4433-810e-24945b8c2774

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Cander_Yetkin_2023.pdf
Size:
1.87 MB
Format:
Adobe Portable Document Format

Collections